Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.
暂无分享，去创建一个
J. Hainsworth | J. Mackey | D. Walde | T. Pintér | A. Wardley | C. Vogel | J. Rolski | M. Rupin | T. Fornander | B. Childs | Á. Rodríguez-Lescure | Miguel Martín | J. Hugh | R. Coleman | V. Houé | T. Pieńkowski | J. Glaspy | L. Provencher | V. Wilson | M. Modiano | J. Guastalla | É. Juhos | A. Sami | C. Price | M. Lindsay | B. Colwell | J. Vinholes | K. Laing | Kimberly A Bassi | P. Whitlock